- Home
- WSFS vs CPRX Comparison
WSFS vs CPRX Comparison
Compare WSFS & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSFS
- CPRX
- Stock Information
- Founded
- WSFS 1980
- CPRX 2002
- Country
- WSFS United States
- CPRX United States
- Employees
- WSFS N/A
- CPRX N/A
- Industry
- WSFS Major Banks
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- WSFS Finance
- CPRX Health Care
- Exchange
- WSFS Nasdaq
- CPRX Nasdaq
- Market Cap
- WSFS 3.3B
- CPRX 2.8B
- IPO Year
- WSFS N/A
- CPRX 2006
- Fundamental
- Price
- WSFS $54.64
- CPRX $21.62
- Analyst Decision
- WSFS Hold
- CPRX Strong Buy
- Analyst Count
- WSFS 4
- CPRX 8
- Target Price
- WSFS $63.67
- CPRX $32.25
- AVG Volume (30 Days)
- WSFS 223.0K
- CPRX 875.3K
- Earning Date
- WSFS 01-27-2025
- CPRX 02-26-2025
- Dividend Yield
- WSFS 1.06%
- CPRX N/A
- EPS Growth
- WSFS 0.23
- CPRX 114.68
- EPS
- WSFS 4.41
- CPRX 1.18
- Revenue
- WSFS $984,948,000.00
- CPRX $460,482,000.00
- Revenue This Year
- WSFS N/A
- CPRX $24.00
- Revenue Next Year
- WSFS $4.04
- CPRX $15.13
- P/E Ratio
- WSFS $12.74
- CPRX $18.37
- Revenue Growth
- WSFS 6.26
- CPRX 32.17
- 52 Week Low
- WSFS $41.00
- CPRX $13.70
- 52 Week High
- WSFS $62.75
- CPRX $24.64
- Technical
- Relative Strength Index (RSI)
- WSFS 44.28
- CPRX 40.14
- Support Level
- WSFS $55.56
- CPRX $22.18
- Resistance Level
- WSFS $57.35
- CPRX $23.59
- Average True Range (ATR)
- WSFS 1.90
- CPRX 0.70
- MACD
- WSFS -0.24
- CPRX -0.17
- Stochastic Oscillator
- WSFS 13.38
- CPRX 11.30
About WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.